4//SEC Filing
MERLO LARRY J 4
Accession 0001127602-21-012779
CIK 0000064803other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 5:26 PM ET
Size
20.9 KB
Accession
0001127602-21-012779
Insider Transaction Report
Form 4
MERLO LARRY J
Executive Vice President
Transactions
- Award
Common Stock
2021-02-01+180,192→ 703,520.941 total - Tax Payment
Common Stock
2021-04-01−8,651→ 632,946.941 total - Tax Payment
Common Stock
2021-04-01$74.30/sh−81,700$6,070,310→ 622,517.941 total
Holdings
- 286,787
Stock Option
Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (286,787 underlying) - 545,419
Stock Option
Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (545,419 underlying) - 688,685.988
Stock Unit
- 338,105
Stock Option
Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (338,105 underlying) - 406,633.497(indirect: By Trust)
Common Stock
- 21,621
Common Stock (restricted)
- 7,548(indirect: By ESOP)
ESOP Common Stock
- 5,153.23
Phantom Stock Credits
Exercise: $1.00→ Common Stock (5,153.23 underlying) - 273,929
Stock Option
Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (273,929 underlying) - 394,091
Stock Option
Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (394,091 underlying) - 478,711
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (478,711 underlying)
Footnotes (13)
- [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.
- [F10]Option became exercisable in four equal annual installments, commencing 4/1/2019.
- [F11]Option became exercisable in four equal annual installments, commencing 4/1/2020.
- [F12]The number of shares subject to the option were calculated using a 30-day average price.
- [F13]Options became exercisable in four equal installments, commencing 4/1/2021.
- [F2]Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.
- [F3]Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021.
- [F4]Each share credit is equivalent to one share; 1-for-1 conversion.
- [F5]Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- [F6]Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- [F7]Option became exercisable in four equal annual installments, commencing 4/1/2016.
- [F8]Option became exercisable in four equal annual installments, commencing 4/1/2017.
- [F9]Option became exercisable in four equal annual installments, commencing 4/3/2018.
Documents
Issuer
CVS HEALTH Corp
CIK 0000064803
Entity typeother
Related Parties
1- filerCIK 0001194413
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 5:26 PM ET
- Size
- 20.9 KB